Atlas Trials

Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial

Clinical trial NCT03551444 · UNKNOWN

Trial details

NCT number
NCT03551444
Sponsor
Ain Shams University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatocellular CarcinomaHepatitis C, Chronic
Start date
2017-10-01
Primary completion
2019-04-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.